A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Trial details
- Registry ID
- NCT07010471
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as relutrigine
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineNCT07010471 | Praxis Precision Medicines | Phase 3 | Active not recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |